Scott Smith
Acuta Capital Partners, Llc
Assets Managed
$141.758M
Holdings
26
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-3.75%(2Q avg: 24.23%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Acuta Capital Partners, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 26 positions.
Assets under management
The assets under management (AUM) of Acuta Capital Partners, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 141.758M in assets, with a quarterly growth rate of -3.75% and a 2-quarter average growth rate of 24.23%. The portfolio is managed by Scott Smith, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
PRAX Praxis Precision Medicines I
| 19.3% | $27.354M 84,901 shares@ $322.19 avg price | Increased 2.25% |
TERN Terns Pharmaceuticals Inc
| 18.44% | $26.137M 495,772 shares@ $52.73 avg price | Decreased -22.18% |
AADI Aadi Bioscience Inc
| 8.3% | $11.766M 3.41M shares@ $3.46 avg price | |
TNGX Tango Therapeutics Inc
| 6.53% | $9.243M 441,831 shares@ $20.93 avg price | Increased 56.28% |
DRUG Bright Minds Biosciences Inc
| 5.77% | $8.172M 111,996 shares@ $72.97 avg price | Increased 32.58% |
STRO Sutro Biopharma Inc
| 4.74% | $6.711M 269,425 shares@ $24.92 avg price | Increased 299.44% |
ERAS Erasca Inc
| 4.05% | $5.737M 354,575 shares@ $16.19 avg price | New Position |
SRZN Surrozen Inc
| 3.56% | $5.035M 172,847 shares@ $29.13 avg price | Decreased -3.12% |
OCUL Ocular Therapeutix Inc
| 3.54% | $5.015M 592,108 shares@ $8.48 avg price | Decreased -43.76% |
CMPX Compass Therapeutics Inc
| 3.17% | $4.492M 849,076 shares@ $5.29 avg price | Decreased -22.33% |
1-10 of 26